Pilot Study on Deep Brain Stimulation for Opioid Use Disorder Initiated
The initiation of a pilot study on deep brain stimulation for opioid use disorder represents a potential shift in treatment paradigms for a challenging condition. Success in this trial could lead to new therapeutic options, impacting existing addiction therapies and strategies for companies in this space.
Phase III
Neurology / Opioid Use Disorder
Status
Initiated
Sponsor
Abbott
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Strategic implication
The initiation of a pilot study on deep brain stimulation for opioid use disorder represents a potential shift in treatment paradigms for a challenging condition. Success in this trial could lead to new therapeutic options, impacting existing addiction therapies and strategies for companies in this space.
Why it matters
The initiation of a pilot study on deep brain stimulation for opioid use disorder represents a potential shift in treatment paradigms for a challenging condition. Success in this trial could lead to new therapeutic options, impacting existing addiction therapies and strategies for companies in this space.
What changed
Trial Update
Analysis
A pilot study is underway to assess the safety and efficacy of deep brain stimulation targeting the nucleus accumbens in patients with treatment-refractory opioid use disorder.
The initiation of a pilot study on deep brain stimulation for opioid use disorder represents a potential shift in treatment paradigms for a challenging condition. Success in this trial could lead to new therapeutic options, impacting existing addiction therapies and strategies for companies in this space.
Monitor results from this pilot study and any subsequent trials that may expand on these findings.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.